Management Change30 Apr 2026, 03:39 pm
Dr. Lal PathLabs Designates Dr. Nakra & Dr. Khera as SMP
AI Summary
Dr. Lal PathLabs Ltd has designated Dr. Reena Nakra (Chief Scientific Officer) and Dr. Saloni Khera (Chief Lab Management Officer) as Senior Management Personnel (SMP) of the company, effective April 30, 2026. This decision was made during the Board of Directors meeting held on the same date, where other key matters were also approved, including financial results, dividend recommendation, acquisition of Shahbazkers Diagnostic Centre Private Limited, incorporation of a wholly-owned subsidiary in Dubai, and re-appointments of directors and auditors.
Key Highlights
- Dr. Reena Nakra and Dr. Saloni Khera designated as Senior Management Personnel (SMP).
- Final dividend of ₹4 per equity share recommended, subject to shareholder approval.
- 100% stake acquisition of Shahbazkers Diagnostic Centre Private Limited approved.
- Incorporation of a wholly-owned subsidiary in Dubai, UAE approved.
- Re-appointment of M/s Ernst & Young LLP as Internal Auditors for FY 2026-27.
Price Impact
More from LALPATHLAB